Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral Therapy

BACKGROUND: All-oral interferon-free regimens for hepatitis C viral (HCV) infection are highly efficacious; however, high cost is a barrier to applicability. Liver allograft recipients are particularly likely to benefit from therapy as HCV often leads to graft dysfunction and loss. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Shahid, Malik, Shahid, Fu, Bo, Chang, Joyce, Nalesnik, Michael, Humar, Abhinav, Shaikh, Obaid S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051027/
https://www.ncbi.nlm.nih.gov/pubmed/27785310
http://dx.doi.org/10.14740/gr694w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051027/
https://www.ncbi.nlm.nih.gov/pubmed/27785310
http://dx.doi.org/10.14740/gr694w

Ejemplares similares